Pixium Vision rises after the successful implantation of its
Medtech activated its first sub-retinal implant (Prima) in a patient with atrophic dry AMD. The shares of the medtech gain about 25% this 26 of January at the end of the morning.
Medtech activated its first sub-retinal implant (Prima) in a patient with atrophic dry AMD. The shares of the medtech gain about 25% this 26 of January at the end of the morning.
The Bionic Vision Specialist announces Successful Implantation in Patient with atrophic dry AMD
Paris start-up Pixium Vision, which is developing bionic vision restoration systems, has seen its share price soar after the announcement of the very first implantation of its new-generation retinal implant PRIMA.
Pixium Vision : Successful first Human activation of “PRIMA” Bionic Vision System
Pixium Vision announced the first implantation and successful activation of Prima, a wireless, new generation sub-retinal photovoltaic implant in a subject with the dry atrophic form of Age-Related Macular Degeneration (dry-AMD).
This is a world’s première announced Thursday evening by Pixium Vision. The activation of its new retinal system implanted in the first patient, with atrophic dry age-related macular degeneration (AMD), allowed her to perceive light signals.
PRIMA, miniaturized wireless photovoltaic sub-retinal implant, elicited visual perception in the first human subject with Atrophic Dry-AMD
Healthcare of the future comes to the City of Science and Industry!
The feasibility clinical study is designed to evaluate PRIMA sub-retinalimplant in patients with Atrophic Dry Age-related Macular Degeneration